David Schuster, NP
Acute Care · Mequon, WINPI 1427723170
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,004 of the $1,202 with a category attached, or 83.5%. It is spread thinly across 10 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $66.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$249
- Actelion Pharmaceuticals US, Inc.$198
- Boston Scientific$138
- AstraZeneca$130
- Edwards Lifesciences$120
- Boehringer Ingelheim$113
- plus $254 from 4 others
What the payments were for
- Food & beverage$1,00484%
- Education$19816%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 2 | $249 |
| Actelion Pharmaceuticals US, Inc. | 2 | $198 |
| Boston Scientific | 2 | $138 |
| AstraZeneca | 2 | $130 |
| Edwards Lifesciences | 1 | $120 |
| Boehringer Ingelheim | 1 | $113 |
| Alnylam Pharmaceuticals Inc. | 1 | $110 |
| Medtronic | 2 | $64 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $52 |
| Novartis | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$249
- Edwards SAPIEN 3 Transcatheter Heart Valve$120
- BRILINTA$114
- JARDIANCE$113
- WATCHMAN Access System$112
- ONPATTRO$110
How this compares
$1,202 in reported general payments places this provider in the 90th percentile of 127 acute care providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $74,261 |
| JardianceEmpagliflozin | 47 | $43,959 |
| XareltoRivaroxaban | 24 | $39,415 |
| OzempicSemaglutide | 19 | $24,567 |
| JanuviaSitagliptin Phosphate | 16 | $18,490 |
| FarxigaDapagliflozin Propanediol | 15 | $17,774 |
| LinzessLinaclotide | 14 | $15,554 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $10,353 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 28 | $5,615 |
| Losartan Potassium | 303 | $3,399 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $3,061 |
| Atorvastatin Calcium | 311 | $3,003 |
| Omeprazole | 163 | $2,352 |
| Pantoprazole Sodium | 159 | $2,036 |
| LantusInsulin Glargine,hum.Rec.Anlog | 19 | $1,987 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $113 | $54,31266 claims |
| AstraZenecaFarxiga | $130 | $17,77415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 127 acute care providers in Wisconsin.
Other acute care in Mequon
- Kelsey CramerMilwaukee$5K
- Billie LawlerMount Pleasant$5K
- Elizabeth LaufenbergMilwaukee$5K
- Joel SchaeveBrookfield$4K
- Avery LebowitzMenasha$4K
- Deborah SauerWausau$4K
- Evgeniya KhenOconomowoc$2K
- Julie PruettMilwaukee$2K
- Craig SchuttaMilwaukee$2K
- Kayla DavisWaukesha$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.